Evidence map›Paper›PMID 41206825›Full record

ArticleAIDS and behavior2026

Navigating the Mpox Outbreak: Insights on Vaccination Decisions and Psychosocial Impacts Among Gay, Bisexual, and Other Men Who Have Sex with Men in Los Angeles.

Elizabeth A Yonko, Connor G Wright, Lauren Rabbottini, Kiana Aminzadeh, Kenneth H Mayer, Katie B Biello, Matthew J Mimiaga

Abstract read
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elizabeth A YonkoDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA. yonkoe@g.ucla.edu.ORCID http://orcid.org/0000-0003-4065-1820
Connor G WrightDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA.
Lauren RabbottiniSchool of Social Work, Boston University, Boston, MA, USA.
Kiana AminzadehDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, MA, USA.
Katie B Biello *The Fenway Institute, Fenway Health, Boston, MA, USA.
Matthew J Mimiaga *Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA.

Funding

Center for AIDS Research, University of California Los Angeles AI152501Providence/Boston CFAR at Brown University P30AI042853
6 · The paper itself

Abstract

The 2022 mpox outbreak significantly impacted gay, bisexual, and other men who have sex with men (MSM) in the U.S., with Los Angeles representing nearly 40% of California cases. Limited data exist on how MSM living with and without HIV navigated the outbreak and their decision-making regarding vaccination. Between November 2023 and March 2024, we conducted a mixed-methods study with 21 cisgender MSM in Los Angeles who completed a semi-structured interview and quantitative survey. Recruitment prioritized diversity in mpox vaccination history, HIV status, race, and ethnicity. Interviews were recorded, transcribed, and analyzed using thematic content analysis; surveys were analyzed using descriptive statistics. Participants had a mean age of 40 years; 33% were living with HIV; 48% identified as Black/African American or mixed-race, 38% White; nearly half identified as Hispanic/Latinx (48%); 57% reported receiving at least one mpox vaccine dose, and 38% reported two doses for maximum protection. Knowledge about mpox transmission, prevention, treatment, and outcomes varied. Participants self-reported hearing that mpox could be transmitted by skin-skin contact (76%), kissing (67%), engaging in oral sex (67%), and contact with semen (33%); 62% had heard there was a treatment for mpox, 14% thought that mpox was not curable, and 48% believed that mpox was likely to cause death. Psychosocial impacts were prominent at both individual and community levels, including fear and distress. Mpox vaccination was motivated by fear and a desire for protection, facilitated by accessible venues and peer influence. Barriers included initially poor availability of vaccine and the specific eligibility criteria requirements for vaccination early on in the epidemic. Logistical challenges, such as long wait times (> 2 h), work hours, lack of transportation, mistrust in research, and confusing initial rollout also presented unique barriers. LGBTQ+ community-based organizations and peer networks were the primary trusted source of mpox-related information. Most initially adopted risk reduction behaviors but generally viewed the mpox response more favorably than COVID-19 due to time differences in vaccine availability. Post-vaccination, many resumed pre-outbreak activities, feeling more prepared for future outbreaks despite some lingering concerns. Findings underscore varied mpox knowledge and significant psychosocial impacts, reminiscent of the early HIV epidemic. Key facilitators and barriers to vaccination highlight the critical reliance on LGBTQ+ community-based organizations and peer networks for sources of trustworthy information. Providing referrals to mental health counseling and other forms of support during vaccination is recommended.

Indexed as

Decision MakingDisease OutbreaksHIV InfectionsMpox, MonkeypoxSexual and Gender MinoritiesVaccinationAdultHealth Knowledge, Attitudes, PracticeHomosexuality, MaleHumansLos AngelesMaleMiddle AgedCOVID-19Gay and bisexual menHIVMen who have sex with menMixed methodsMonkeypoxMpoxMpox vaccinationMSM

Identifiers

PMID41206825
PMCPMC13076419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.